VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HSIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HSICHenry Schein, Inc.
$86.84$9.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

HSIC logoHenry Schein, Inc.(HSIC)Earnings, Financials & Key Ratios

HSIC•NASDAQ
$86.84
26.6× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryMedical DistributionSub-IndustryDental and Office-Based Distribution
AboutHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.Show more
  • Revenue$13.18B+4.0%
  • EBITDA$1.07B+4.2%
  • Net Income$398M+2.1%
  • EPS (Diluted)3.27+7.2%
  • Gross Margin29.14%-1.9%
  • EBITDA Margin8.11%+0.2%
  • Operating Margin5.75%
  • Net Margin3.02%-1.9%
  • ROE8.27%+5.9%

HSIC Price & Volume

Henry Schein, Inc. (HSIC) stock price & volume — 10-year historical chart

Loading chart...

Margin Expansion Faces Rising Debt Leverage Risks

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Stable
Profitability:Moderate
Financial:Adequate
Cash Flow:Mixed
Primary Risk:Margin compression from DSOs

Key Thesis Takeaways

  • Henry Schein demonstrates resilient top-line growth, evidenced by a 6.3% revenue increase in 2026Q1, yet faces significant headwinds from constrained operating leverage and increasing debt levels.
  • While gross margins have improved to 31.8%, the company's reliance on debt-funded capital allocation and the potential for margin compression from large Dental Service Organizations create a complex risk-reward profile.
  • Investors should monitor the sustainability of cash conversion, which saw an OCF/NI ratio of -0.91 in 2026Q1, against the backdrop of a $4.3 billion goodwill concentration.

Verdict Logic

while the forward P/E of 15.88 suggests a reasonable valuation, the inconsistent cash conversion and rising debt-to-equity ratio of 0.78 warrant a cautious, wait-and-see approach.

HSIC Growth Metrics

Henry Schein, Inc. (HSIC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.18%
5 Years5.43%
3 Years1.4%
TTM5.64%

Profit CAGR

10 Years-1.84%
5 Years-0.21%
3 Years-9.56%
TTM-2.95%

EPS CAGR

10 Years1.38%
5 Years3.15%
3 Years-5.78%
TTM3.44%

Return on Capital

10 Years13.41%
5 Years11.79%
3 Years9.79%
Last Year9.84%

HSIC Recent Earnings

Henry Schein, Inc. (HSIC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$1.32+10.0%
$1.20
Rev
$3.4B+0.8%
$3.3B
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$1.34+3.1%
$1.30
Rev
$3.4B+2.7%
$3.3B
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$1.38+8.7%
$1.27
Rev
$3.3B-0.2%
$3.3B
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$1.10-6.8%
$1.18
Rev
$3.2B-1.1%
$3.3B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$1.32vs $1.20+10.0%
$3.4Bvs $3.3B+0.8%
Q1 2026Feb 24, 2026
$1.34vs $1.30+3.1%
$3.4Bvs $3.3B+2.7%
Q4 2025Nov 4, 2025
$1.38vs $1.27+8.7%
$3.3Bvs $3.3B-0.2%
Q3 2025Aug 5, 2025
$1.10vs $1.18-6.8%
$3.2Bvs $3.3B-1.1%
Based on last 12 quarters of dataView full earnings history →

Latest HSIC News

Recent stock market news and headlines for Henry Schein, Inc. (HSIC)

Zacks Investment Research·22h ago
Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PRNewsWire·Jun 30, 2026
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide

MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace, and Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced a new strategic partnership designed to help dental practices address ongoing staffing challenges and maintain continuity of patient care. Through this collaboration between GoTu and Henry Schein Dental Recruitment Services (a division of Henry Schein Financial Enterprises, LLC, a wholly-owned subsidiary of Henry Schein), dental practices will gain expanded access to GoTu's technology-enabled platform, which connects offices with qualified dental hygienists, dental assistants, and associate dentists for both temporary and permanent staffing needs.

Zacks Investment Research·Jun 23, 2026
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Seeking Alpha·Jun 22, 2026
Henry Schein: Smile Because The Upside Isn't Over

Henry Schein remains a dominant global provider in dental and medical practitioner supplies, with strong market shares and ongoing revenue growth. HSIC's Q1 2026 revenue grew 6.3% year-over-year, driven by robust global dental merchandise and equipment demand, particularly in aging and expanding populations. Profitability metrics are mixed, but adjusted net income and EBITDA are rising; management guides for 3–5% revenue growth and mid-single-digit EBITDA growth in 2026.

Peers Comparison

Key metrics vs top competitors for Henry Schein, Inc. (HSIC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HSIC logoHSICHenry Schein, Inc.Current
$86.84$9.89B26.564.03%3.02%8.27%—
DXPE logoDXPEDXP Enterprises, Inc.
$155.29$2.41B28.9711.89%4.27%17.9%—
OMI logoOMIOwens & Minor, Inc.
$2.24$171.11M-0.16-74.19%-39.85%——
MCK logoMCKMcKesson Corporation
$807.33$97.04B21.0412.36%1.18%——
CAH logoCAHCardinal Health, Inc.
$239.71$56.41B37.16-1.87%0.62%——
XRAY logoXRAYDENTSPLY SIRONA Inc.
$12.19$2.44B-4.06-2.98%-17.06%-41.19%—

Compare HSIC vs Peers

Henry Schein, Inc. (HSIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXPE

Most directly comparable listed peer for HSIC.

Scale Benchmark

vs SYK

Larger-name benchmark to compare HSIC against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXPE, OMI, MCK, CAH

HSIC SEC Filings & Documents

Henry Schein, Inc. (HSIC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 22, 2026·SEC

Material company update

May 5, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 5, 2025·SEC

Get notified when HSIC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HSIC Frequently Asked Questions

Henry Schein, Inc. (HSIC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Henry Schein, Inc.'s revenue?

Henry Schein, Inc. (HSIC) reported $13.38B in revenue for fiscal year 2025. This represents a 1513% increase from $830.0M in 1996.

How fast is Henry Schein, Inc. growing?

Henry Schein, Inc. (HSIC) grew revenue by 4.0% over the past year. Growth has been modest.

Is HSIC profitable?

Yes, Henry Schein, Inc. (HSIC) is profitable, generating $395.0M in net income for fiscal year 2025 (3.0% net margin).

Dividend & Returns
What is HSIC's return on equity?

Henry Schein, Inc. (HSIC) has a return on equity (ROE) of 8.3%. This is below average, suggesting room for improvement.

What is Henry Schein, Inc.'s free cash flow?

Henry Schein, Inc. (HSIC) generated $431.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in HSIC back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →